{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T22:56:14Z","timestamp":1769727374044,"version":"3.49.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T00:00:00Z","timestamp":1710806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T00:00:00Z","timestamp":1710806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-024-05540-5","type":"journal-article","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T06:51:21Z","timestamp":1710831081000},"page":"1013-1023","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Giant cell arteritis: insights from a monocentric retrospective cohort study"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5574-2939","authenticated-orcid":false,"given":"Fatima","family":"Alnaimat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1762-0575","authenticated-orcid":false,"given":"Hamza","family":"Alduradi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6921-7748","authenticated-orcid":false,"given":"Soud","family":"Al-Qasem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1580-563X","authenticated-orcid":false,"given":"Hamza","family":"Ghazzal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2543-0456","authenticated-orcid":false,"given":"Mo\u2019ath","family":"Alsarhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,19]]},"reference":[{"key":"5540_CR1","doi-asserted-by":"publisher","unstructured":"Casta\u00f1eda S et al (Mar. 2022) Advances in the treatment of Giant Cell Arteritis. J Clin Med 11(6). https:\/\/doi.org\/10.3390\/JCM11061588","DOI":"10.3390\/JCM11061588"},{"key":"5540_CR2","doi-asserted-by":"publisher","unstructured":"Jennette JC et al (2013) Jan., 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65(1):1\u201311. https:\/\/doi.org\/10.1002\/ART.37715","DOI":"10.1002\/ART.37715"},{"key":"5540_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/MED\/9780199659869.003.0002","volume":"no August","author":"Watts","year":"2014","unstructured":"Watts, Scott (2014) Epidemiology of vasculitis. Case Stud Clin Psychol Science: Bridging Gap Sci Pract no August 1\u20137. https:\/\/doi.org\/10.1093\/MED\/9780199659869.003.0002","journal-title":"Case Stud Clin Psychol Science: Bridging Gap Sci Pract"},{"key":"5540_CR4","doi-asserted-by":"publisher","unstructured":"Koster MJ, Matteson EL, Warrington KJ (2018) Large-vessel giant cell arteritis: diagnosis, monitoring and management. Rheumatology (Oxford) 57(suppl_2):ii32\u2013ii42. https:\/\/doi.org\/10.1093\/RHEUMATOLOGY\/KEX424","DOI":"10.1093\/RHEUMATOLOGY\/KEX424"},{"key":"5540_CR5","doi-asserted-by":"publisher","unstructured":"Maz M et al (2021) 2021 American College of Rheumatology\/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis. Arthritis Rheumatol 73(8):1349\u20131365. https:\/\/doi.org\/10.1002\/ART.41774","DOI":"10.1002\/ART.41774"},{"key":"5540_CR6","doi-asserted-by":"publisher","unstructured":"Hellmich B et al (Jan. 2020) 2018 update of the EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 79(1):19\u2013130. https:\/\/doi.org\/10.1136\/ANNRHEUMDIS-2019-215672","DOI":"10.1136\/ANNRHEUMDIS-2019-215672"},{"key":"5540_CR7","doi-asserted-by":"publisher","unstructured":"Sonnenblick M, Nesher G, Friedlander Y, Rubinow A (1994) Giant cell arteritis in Jerusalem: a 12-year epidemiological study. Br J Rheumatol 33(10):938\u2013941. https:\/\/doi.org\/10.1093\/RHEUMATOLOGY\/33.10.938","DOI":"10.1093\/RHEUMATOLOGY\/33.10.938"},{"issue":"2","key":"5540_CR8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/J.BERH.2004.11.006","volume":"19","author":"RA Watts","year":"2005","unstructured":"Watts RA, Lane S, Scott DGI (2005) What is known about the epidemiology of the vasculitides? Best Pract Res Clin Rheumatol 19(2):191\u2013207. https:\/\/doi.org\/10.1016\/J.BERH.2004.11.006","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"5540_CR9","doi-asserted-by":"publisher","unstructured":"Kobayashi S, Fujimoto S (2013) Epidemiology of vasculitides: differences between Japan, Europe and North America. Clin Exp Nephrol 17(5):611. https:\/\/doi.org\/10.1007\/S10157-013-0813-9","DOI":"10.1007\/S10157-013-0813-9"},{"key":"5540_CR10","doi-asserted-by":"publisher","unstructured":"Duhaut P, Bosshard S, Ducroix JP (2004) Is giant cell arteritis an infectious disease? Biological and epidemiological evidence. Presse Med 33(19 Pt 2):1403\u20131408. https:\/\/doi.org\/10.1016\/S0755-4982(04)98939-7","DOI":"10.1016\/S0755-4982(04)98939-7"},{"key":"5540_CR11","doi-asserted-by":"publisher","unstructured":"Chaudhry IA, Shamsi FA, Elzaridi E, Arat YO, Bosley TM, Riley FC (2007) Epidemiology of giant-cell arteritis in an arab population: a 22\u2010year study. Br J Ophthalmol 91(6):715. https:\/\/doi.org\/10.1136\/BJO.2006.108845","DOI":"10.1136\/BJO.2006.108845"},{"key":"5540_CR12","doi-asserted-by":"publisher","unstructured":"Khalifa M, Karmani M, Jaafoura NG, Kaabia N, Letaief AO, Bahri F (2009) Epidemiological and clinical features of giant cell arteritis in Tunisia. Eur J Intern Med 20(2):208\u2013212. https:\/\/doi.org\/10.1016\/J.EJIM.2008.07.030","DOI":"10.1016\/J.EJIM.2008.07.030"},{"key":"5540_CR13","unstructured":"The incidence of giant cell arteritis in Jerusalem over a 25-year period: annual and seasonal fluctuations - PubMed. Accessed: Aug. 10, 2023. [Online]. Available: https:\/\/pubmed.ncbi.nlm.nih.gov\/17428357\/"},{"key":"5540_CR14","doi-asserted-by":"publisher","unstructured":"Shahin AA et al (2018) The distribution and outcome of vasculitic syndromes among egyptians: a multi-centre study including 630 patients. Egypt Rheumatologist 40(4):243\u2013248. https:\/\/doi.org\/10.1016\/J.EJR.2018.01.001","DOI":"10.1016\/J.EJR.2018.01.001"},{"key":"5540_CR15","doi-asserted-by":"publisher","unstructured":"Attia DHS, Abdel RA, Noor, Salah S (2019) Shedding light on vasculitis in Egypt: a multicenter retrospective cohort study of characteristics, management, and outcome. Clin Rheumatol 38(6):1675\u20131684. https:\/\/doi.org\/10.1007\/S10067-019-04441-4","DOI":"10.1007\/S10067-019-04441-4"},{"key":"5540_CR16","doi-asserted-by":"publisher","unstructured":"Alnaimat F et al (2021) Clinical and technical determinants of positive temporal artery biopsy: a retrospective cohort study. Rheumatol Int 41(12):2157\u20132166. https:\/\/doi.org\/10.1007\/S00296-021-05028-6","DOI":"10.1007\/S00296-021-05028-6"},{"issue":"1","key":"5540_CR17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1023\/A:1006167213695\/METRICS","volume":"22","author":"TM Bosley","year":"1998","unstructured":"Bosley TM, Riley FC (1998) Giant cell arteritis in Saudi Arabia. Int Ophthalmol 22(1):59\u201360. https:\/\/doi.org\/10.1023\/A:1006167213695\/METRICS","journal-title":"Int Ophthalmol"},{"key":"5540_CR18","doi-asserted-by":"publisher","unstructured":"Habib HM, Essa AA, Hassan AA (Feb. 2012) Color duplex ultrasonography of temporal arteries: role in diagnosis and follow-up of suspected cases of temporal arteritis. Clin Rheumatol 31(2):231\u2013237. https:\/\/doi.org\/10.1007\/S10067-011-1808-0","DOI":"10.1007\/S10067-011-1808-0"},{"key":"5540_CR19","doi-asserted-by":"publisher","unstructured":"Gruener AM, Chang JR, Bosley TM, Al-Sadah ZM, Kum C, McCulley TJ (2017) Relative frequencies of arteritic and nonarteritic anterior ischemic optic neuropathy in an arab population. J Neuroophthalmol 37(4):382\u2013385. https:\/\/doi.org\/10.1097\/WNO.0000000000000491","DOI":"10.1097\/WNO.0000000000000491"},{"key":"5540_CR20","doi-asserted-by":"publisher","unstructured":"Mehta K et al (2022) The utility of the bilateral temporal artery biopsy for diagnosis of giant cell arteritis. J Vasc Surg 76(6):1704\u20131709. https:\/\/doi.org\/10.1016\/j.jvs.2022.04.043","DOI":"10.1016\/j.jvs.2022.04.043"},{"key":"5540_CR21","doi-asserted-by":"publisher","unstructured":"Oumerzouk J, El Filali O, Zbitou A, Slioui B, Belasri S, Kissani N (2023) Neurological complications of giant cell arteritis: A study of 15 cases and a review of the literature. J Fr Ophtalmol 46(3):211\u2013215. https:\/\/doi.org\/10.1016\/J.JFO.2022.06.013","DOI":"10.1016\/J.JFO.2022.06.013"},{"issue":"2","key":"5540_CR22","doi-asserted-by":"publisher","first-page":"237","DOI":"10.5144\/0256-4947.1997.237","volume":"17","author":"A Al Tahan","year":"1997","unstructured":"Al Tahan A, Al Rayess M, Abduljabbar M, Moallem MA (1997) Giant cell arteritis: report of two Saudi patients and review of the literature. Ann Saudi Med 17(2):237\u2013239. https:\/\/doi.org\/10.5144\/0256-4947.1997.237","journal-title":"Ann Saudi Med"},{"key":"5540_CR23","doi-asserted-by":"publisher","unstructured":"Achar KN, Al-alousi SS, Patrick JP (1994) Biliary ultrastructural changes in the liver in a case of giant cell arteritis. Br J Rheumatol 33(2):161\u2013164. https:\/\/doi.org\/10.1093\/RHEUMATOLOGY\/33.2.161","DOI":"10.1093\/RHEUMATOLOGY\/33.2.161"},{"key":"5540_CR24","unstructured":"\u2019Al-Alawi E, \u2019Al-Baharna I, \u2019Malik A, \u2019Al-Shoorqi E Giant cell arteritis: A typical case of ischaemic optic neuropathy due to GCA. International Journal of Medicine 5(2):106\u2013108."},{"key":"5540_CR25","doi-asserted-by":"publisher","unstructured":"Haddad FG, El-Nemnoum R, Haddad F, Maalouly G, El-Rassi I (2008) Giant cell arteritis of the aorta: catastrophic complications without a preexisting aneurysm. Eur J Intern Med 19(7). https:\/\/doi.org\/10.1016\/J.EJIM.2008.03.011","DOI":"10.1016\/J.EJIM.2008.03.011"},{"key":"5540_CR26","doi-asserted-by":"publisher","unstructured":"Haddad F, El-Rassi I, Haddad FG, Nemnoum R, Jebara VA (2008) Aorto-atrial fistula 10 days after dissection repair in giant cell arteritis. Ann Thorac Surg 86(5):1672\u20131674. https:\/\/doi.org\/10.1016\/J.ATHORACSUR.2008.04.095","DOI":"10.1016\/J.ATHORACSUR.2008.04.095"},{"key":"5540_CR27","doi-asserted-by":"publisher","unstructured":"Mustafa KN, Hadidy A, Joudeh A, Obeidat FN, Abdulfattah KW (2015) Spinal cord infarction in giant cell arteritis associated with scalp necrosis. Rheumatol Int 35(2):377\u2013381. https:\/\/doi.org\/10.1007\/S00296-014-3089-9","DOI":"10.1007\/S00296-014-3089-9"},{"key":"5540_CR28","doi-asserted-by":"publisher","unstructured":"Wang SJ, Olson NJ, Kieffer KA (2016) A picture\u2019s Worth: giant cell arteritis. Am J Med 129(9):942\u2013944. https:\/\/doi.org\/10.1016\/j.amjmed.2016.04.029","DOI":"10.1016\/j.amjmed.2016.04.029"},{"key":"5540_CR29","doi-asserted-by":"publisher","unstructured":"Albarrak AM, Mohammad Y, Hussain S, Husain S, Muayqil T (2018) Simultaneous bilateral posterior ischemic optic neuropathy secondary to giant cell arteritis: a case presentation and review of the literature. BMC Ophthalmol 18(1). https:\/\/doi.org\/10.1186\/S12886-018-0994-9","DOI":"10.1186\/S12886-018-0994-9"},{"key":"5540_CR30","doi-asserted-by":"publisher","unstructured":"Idoudi S et al (2020) Scalp Necrosis Revealing Severe Giant-Cell Arteritis. Case Rep Med 2020. https:\/\/doi.org\/10.1155\/2020\/8130404","DOI":"10.1155\/2020\/8130404"},{"key":"5540_CR31","doi-asserted-by":"publisher","unstructured":"AlNuaimi D, Ansari H, Menon R, AlKetbi R, George A (2020) Large vessel vasculitis and the rising role of FDG PET-CT: a case report and review of literature. Radiol Case Rep 15(11):2246. https:\/\/doi.org\/10.1016\/J.RADCR.2020.08.066","DOI":"10.1016\/J.RADCR.2020.08.066"},{"key":"5540_CR32","doi-asserted-by":"publisher","unstructured":"Mursi AM, Mirghani HO, Elbeialy AA (2022) A Case Report of Post COVID19 Giant Cell Arteritis and Polymyalgia Rheumatica With Visual Loss. Clin Med Insights Case Rep 15. https:\/\/doi.org\/10.1177\/11795476221088472","DOI":"10.1177\/11795476221088472"},{"key":"5540_CR33","doi-asserted-by":"publisher","unstructured":"Dagostin MA, Pereira RMR, Dagostin MA, Pereira RMR (2020) Giant Cell Arteritis: Current Advances in Pathogenesis and Treatment. Vascular Biology - Selection of Mechanisms and Clinical Applications. https:\/\/doi.org\/10.5772\/INTECHOPEN.91018","DOI":"10.5772\/INTECHOPEN.91018"},{"key":"5540_CR34","doi-asserted-by":"publisher","unstructured":"Chean CS et al (2019) Characteristics of patients with giant cell arteritis who experience visual symptoms. Rheumatol Int 39(10):1789\u20131796. https:\/\/doi.org\/10.1007\/S00296-019-04422-5\/TABLES\/3","DOI":"10.1007\/S00296-019-04422-5\/TABLES\/3"},{"key":"5540_CR35","doi-asserted-by":"publisher","unstructured":"Gonzalez Chiappe S et al (2022) Incidence of giant cell arteritis in six districts of Paris, France (2015\u20132017). Rheumatol Int 42(10):1721\u20131728. https:\/\/doi.org\/10.1007\/S00296-022-05167-4\/METRICS","DOI":"10.1007\/S00296-022-05167-4\/METRICS"},{"key":"5540_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/S00296-023-05446-8","author":"LI Sakkas","year":"2023","unstructured":"Sakkas LI, Chikanza IC (2023) Sex bias in immune response: it is time to include the sex variable in studies of autoimmune rheumatic diseases. Rheumatol Int. https:\/\/doi.org\/10.1007\/S00296-023-05446-8","journal-title":"Rheumatol Int"},{"key":"5540_CR37","doi-asserted-by":"publisher","unstructured":"Ince B et al (2021) Long-term follow-up of 89 patients with giant cell arteritis: a retrospective observational study on disease characteristics, flares and organ damage. Rheumatol Int 41(2):439\u2013448. https:\/\/doi.org\/10.1007\/S00296-020-04730-1\/METRICS","DOI":"10.1007\/S00296-020-04730-1\/METRICS"},{"key":"5540_CR38","doi-asserted-by":"publisher","unstructured":"Mohan SV, Liao YJ, Kim JW, Goronzy JJ, Weyand CM (2011) Giant cell arteritis: immune and vascular aging as disease risk factors. Arthritis Res Ther 13(4):231. https:\/\/doi.org\/10.1186\/AR3358","DOI":"10.1186\/AR3358"},{"key":"5540_CR39","doi-asserted-by":"publisher","unstructured":"Ciccia F, Macaluso F, Mauro D, Nicoletti GF, Croci S, Salvarani C (2021) New insights into the pathogenesis of giant cell arteritis: are they relevant for precision medicine? Lancet Rheumatol 3(12):e874\u2013e885. https:\/\/doi.org\/10.1016\/S2665-9913(21)00253-8","DOI":"10.1016\/S2665-9913(21)00253-8"},{"key":"5540_CR40","unstructured":"Immunohistochemical analysis of lymphoid and macrophage cell subsets and their immunologic activation markers in temporal arteritis. Influence of corticosteroid treatment - PubMed. Accessed: Aug. 10, 2023. [Online]. Available: https:\/\/pubmed.ncbi.nlm.nih.gov\/2787641\/"},{"issue":"10","key":"5540_CR41","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/NRRHEUM.2017.142","volume":"13","author":"C Dejaco","year":"2017","unstructured":"Dejaco C, Brouwer E, Mason JC, Buttgereit F, Matteson EL, Dasgupta B (2017) Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunities. Nat Rev Rheumatol 13(10):578\u2013592. https:\/\/doi.org\/10.1038\/NRRHEUM.2017.142","journal-title":"Nat Rev Rheumatol"},{"key":"5540_CR42","unstructured":"Fast track pathway reduces sight loss in giant cell arteritis: results of a longitudinal observational cohort study - PubMed. Accessed: Aug. 10, 2023. [Online]. Available: https:\/\/pubmed.ncbi.nlm.nih.gov\/26016758\/"},{"key":"5540_CR43","doi-asserted-by":"publisher","unstructured":"Gonzalez-Gay MA, Barros S, Lopez-Diaz MJ, Garcia-Porrua C, Sanchez-Andrade A, Llorca J (2005) Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients. Medicine 84(5):269\u2013276. https:\/\/doi.org\/10.1097\/01.MD.0000180042.42156.D1","DOI":"10.1097\/01.MD.0000180042.42156.D1"},{"key":"5540_CR44","doi-asserted-by":"publisher","unstructured":"Saleh M, Turesson C, Englund M, Merkel PA, Mohammad AJ (2016) Visual complications in patients with biopsy-proven giant cell arteritis: a Population-based study. J Rheumatol 43(8):1559. https:\/\/doi.org\/10.3899\/JRHEUM.151033","DOI":"10.3899\/JRHEUM.151033"},{"key":"5540_CR45","doi-asserted-by":"publisher","unstructured":"Ji J, Dimitrijevic I, Sundquist J, Sundquist K, Z\u00f6ller B (2017) Risk of ocular manifestations in patients with giant cell arteritis: a nationwide study in Sweden. Scand J Rheumatol 46(6):484\u2013489. https:\/\/doi.org\/10.1080\/03009742.2016.1266030","DOI":"10.1080\/03009742.2016.1266030"},{"key":"5540_CR46","doi-asserted-by":"publisher","unstructured":"Weyand CM, Goronzy JJ (2003) Giant-Cell Arteritis and Polymyalgia Rheumatica. Ann Intern Med 139(6). https:\/\/doi.org\/10.7326\/0003-4819-139-6-200309160-00015","DOI":"10.7326\/0003-4819-139-6-200309160-00015"},{"issue":"6","key":"5540_CR47","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1136\/ARD.58.6.335","volume":"58","author":"P Duhaut","year":"1999","unstructured":"Duhaut P et al (1999) Biopsy proven and biopsy negative temporal arteritis: differences in clinical spectrum at the onset of the disease. Ann Rheum Dis 58(6):335. https:\/\/doi.org\/10.1136\/ARD.58.6.335","journal-title":"Ann Rheum Dis"},{"key":"5540_CR48","doi-asserted-by":"publisher","unstructured":"Kermani TA et al (2012) Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis. Semin Arthritis Rheum 41(6):866\u2013871. https:\/\/doi.org\/10.1016\/J.SEMARTHRIT.2011.10.005","DOI":"10.1016\/J.SEMARTHRIT.2011.10.005"},{"key":"5540_CR49","doi-asserted-by":"publisher","unstructured":"Kokloni IN, Aligianni SI, Makri O, Daoussis D (2022) Vision loss in giant cell arteritis: case-based review. Rheumatol Int 42(10):1855\u20131862. https:\/\/doi.org\/10.1007\/S00296-022-05160-X\/METRICS","DOI":"10.1007\/S00296-022-05160-X\/METRICS"},{"issue":"2","key":"5540_CR50","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1136\/ARD.45.2.136","volume":"45","author":"M De Silva","year":"1986","unstructured":"De Silva M, Hazleman BL (1986) Azathioprine in giant cell arteritis\/polymyalgia rheumatica: a double-blind study. Ann Rheum Dis 45(2):136\u2013138. https:\/\/doi.org\/10.1136\/ARD.45.2.136","journal-title":"Ann Rheum Dis"},{"key":"5540_CR51","doi-asserted-by":"publisher","unstructured":"Mahr AD et al (2007) Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis. Arthritis Rheum 56(8):2789\u20132797. https:\/\/doi.org\/10.1002\/ART.22754","DOI":"10.1002\/ART.22754"},{"key":"5540_CR52","doi-asserted-by":"publisher","unstructured":"Stone JH et al (2017) Trial of Tocilizumab in Giant-Cell Arteritis. New England Journal of Medicine 377(4):317\u2013328. https:\/\/doi.org\/10.1056\/NEJMOA1613849\/SUPPL_FILE\/NEJMOA1613849_DISCLOSURES.PDF","DOI":"10.1056\/NEJMOA1613849\/SUPPL_FILE\/NEJMOA1613849_DISCLOSURES.PDF"},{"issue":"3","key":"5540_CR53","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/BF03325257","volume":"24","author":"S Sciascia","year":"2012","unstructured":"Sciascia S et al (2012) Mycophenolate mofetil as steroid-sparing treatment for elderly patients with giant cell arteritis: report of three cases. Aging Clin Exp Res 24(3):273\u2013277. https:\/\/doi.org\/10.1007\/BF03325257","journal-title":"Aging Clin Exp Res"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05540-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-024-05540-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05540-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T03:40:07Z","timestamp":1716349207000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-024-05540-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,19]]},"references-count":53,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["5540"],"URL":"https:\/\/doi.org\/10.1007\/s00296-024-05540-5","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,19]]},"assertion":[{"value":"24 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"all authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No part of this manuscript is copied or published elsewhere in whole or in part in any language.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}